Cite
HARVARD Citation
Tang, X. et al. (2017). Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation. Molecular cancer. 16 (1), pp. 1-13. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tang, X. et al. (2017). Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation. Molecular cancer. 16 (1), pp. 1-13. [Online].